Mesalamine (Lialda) Market Report

Global and Region Mesalamine (Lialda) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：168
  • REPORT CODE：GMM920927
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Mesalamine (Lialda) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Mesalamine (Lialda)market, defines the market attractiveness level of Mesalamine (Lialda) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Mesalamine (Lialda) industry, describes the types of Mesalamine (Lialda) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mesalamine (Lialda) market and the development prospects and opportunities of Mesalamine (Lialda) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mesalamine (Lialda) market in Chapter 13.

    By Player:

    • Shanghai Pharmaceutical

    • KWAI FA Pharmaceutical Group

    • Ethypharm Pharmaceutical

    • Heilongjiang Tianhong Pharmaceutical

    • Ferring

    • Holy Stone Healthcare

    • HENGCHENG PHARMACEUTICAL

    • Lupin

    • DrFalk Pharma

    • Giuliani

    • Tillotts Pharma

    • Zeria

    By Type:

    • Enemas

    • Tablets

    • Suppositories

    • Other

    By End-User:

    • Colitis

    • Crohn's Disease

    • Proctitis

    • Diarrheal Irritable Bowel Syndrome

    • Diverticulitis

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Mesalamine (Lialda) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Mesalamine (Lialda) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Mesalamine (Lialda) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Mesalamine (Lialda) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Mesalamine (Lialda) Market Analysis and Outlook to 2022

    • 7.1 Global Mesalamine (Lialda) Consumption (2017-2022)

    • 7.2 United States Mesalamine (Lialda) Consumption (2017-2022)

    • 7.3 Europe Mesalamine (Lialda) Consumption (2017-2022)

    • 7.4 China Mesalamine (Lialda) Consumption (2017-2022)

    • 7.5 Japan Mesalamine (Lialda) Consumption (2017-2022)

    • 7.6 India Mesalamine (Lialda) Consumption (2017-2022)

    • 7.7 South Korea Mesalamine (Lialda) Consumption (2017-2022)

    8 Region and Country-wise Mesalamine (Lialda) Market Analysis and Outlook to 2028

    • 8.1 Global Mesalamine (Lialda) Consumption Forecast (2022-2028)

    • 8.2 United States Mesalamine (Lialda) Consumption Forecast (2022-2028)

    • 8.3 Europe Mesalamine (Lialda) Consumption Forecast (2022-2028)

    • 8.4 China Mesalamine (Lialda) Consumption Forecast (2022-2028)

    • 8.5 Japan Mesalamine (Lialda) Consumption Forecast (2022-2028)

    • 8.6 India Mesalamine (Lialda) Consumption Forecast (2022-2028)

    • 8.7 South Korea Mesalamine (Lialda) Consumption Forecast (2022-2028)

    9 Global Mesalamine (Lialda) Market Outlook by Types and Applications to 2022

    • 9.1 Global Mesalamine (Lialda) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Enemas Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Suppositories Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Mesalamine (Lialda) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Colitis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Crohn's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Proctitis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Diarrheal Irritable Bowel Syndrome Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Diverticulitis Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Mesalamine (Lialda) Market Outlook by Types and Applications to 2028

    • 10.1 Global Mesalamine (Lialda) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Enemas Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Suppositories Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Mesalamine (Lialda) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Colitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Proctitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Diarrheal Irritable Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Diverticulitis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Mesalamine (Lialda) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Mesalamine (Lialda) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Mesalamine (Lialda) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Mesalamine (Lialda) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Mesalamine (Lialda) Market Competitive Analysis

    • 14.1 Shanghai Pharmaceutical

      • 14.1.1 Shanghai Pharmaceutical Company Details

      • 14.1.2 Shanghai Pharmaceutical Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Shanghai Pharmaceutical Mesalamine (Lialda) Product and Service

    • 14.2 KWAI FA Pharmaceutical Group

      • 14.2.1 KWAI FA Pharmaceutical Group Company Details

      • 14.2.2 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product and Service

    • 14.3 Ethypharm Pharmaceutical

      • 14.3.1 Ethypharm Pharmaceutical Company Details

      • 14.3.2 Ethypharm Pharmaceutical Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Ethypharm Pharmaceutical Mesalamine (Lialda) Product and Service

    • 14.4 Heilongjiang Tianhong Pharmaceutical

      • 14.4.1 Heilongjiang Tianhong Pharmaceutical Company Details

      • 14.4.2 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product and Service

    • 14.5 Ferring

      • 14.5.1 Ferring Company Details

      • 14.5.2 Ferring Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ferring Mesalamine (Lialda) Product and Service

    • 14.6 Holy Stone Healthcare

      • 14.6.1 Holy Stone Healthcare Company Details

      • 14.6.2 Holy Stone Healthcare Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Holy Stone Healthcare Mesalamine (Lialda) Product and Service

    • 14.7 HENGCHENG PHARMACEUTICAL

      • 14.7.1 HENGCHENG PHARMACEUTICAL Company Details

      • 14.7.2 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product and Service

    • 14.8 Lupin

      • 14.8.1 Lupin Company Details

      • 14.8.2 Lupin Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Lupin Mesalamine (Lialda) Product and Service

    • 14.9 DrFalk Pharma

      • 14.9.1 DrFalk Pharma Company Details

      • 14.9.2 DrFalk Pharma Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 DrFalk Pharma Mesalamine (Lialda) Product and Service

    • 14.10 Giuliani

      • 14.10.1 Giuliani Company Details

      • 14.10.2 Giuliani Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Giuliani Mesalamine (Lialda) Product and Service

    • 14.11 Tillotts Pharma

      • 14.11.1 Tillotts Pharma Company Details

      • 14.11.2 Tillotts Pharma Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Tillotts Pharma Mesalamine (Lialda) Product and Service

    • 14.12 Zeria

      • 14.12.1 Zeria Company Details

      • 14.12.2 Zeria Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Zeria Mesalamine (Lialda) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Mesalamine (Lialda)

    • Figure Mesalamine (Lialda) Picture

    • Table Global Mesalamine (Lialda) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mesalamine (Lialda) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mesalamine (Lialda) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Mesalamine (Lialda) Consumption by Country (2017-2022)

    • Figure United States Mesalamine (Lialda) Consumption and Growth Rate (2017-2022)

    • Table Europe Mesalamine (Lialda) Consumption and Growth Rate (2017-2022)

    • Figure China Mesalamine (Lialda) Consumption and Growth Rate (2017-2022)

    • Figure Japan Mesalamine (Lialda) Consumption and Growth Rate (2017-2022)

    • Figure India Mesalamine (Lialda) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Mesalamine (Lialda) Consumption and Growth Rate (2017-2022)

    • Figure Global Mesalamine (Lialda) Consumption Forecast by Country (2022-2028)

    • Figure United States Mesalamine (Lialda) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Mesalamine (Lialda) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Mesalamine (Lialda) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Mesalamine (Lialda) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Mesalamine (Lialda) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Mesalamine (Lialda) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enemas Consumption and Growth Rate (2017-2022)

    • Figure Global Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Suppositories Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Colitis Consumption and Growth Rate (2017-2022)

    • Figure Global Crohn's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Proctitis Consumption and Growth Rate (2017-2022)

    • Figure Global Diarrheal Irritable Bowel Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Diverticulitis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Enemas Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Suppositories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Proctitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diarrheal Irritable Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diverticulitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Mesalamine (Lialda) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Mesalamine (Lialda) Export by Region (Top 5 Countries) (2017-2028)

    • Table Shanghai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Shanghai Pharmaceutical Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Pharmaceutical Mesalamine (Lialda) Product and Service

    • Table KWAI FA Pharmaceutical Group (Foundation Year, Company Profile and etc.)

    • Table KWAI FA Pharmaceutical Group Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product and Service

    • Table Ethypharm Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Ethypharm Pharmaceutical Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethypharm Pharmaceutical Mesalamine (Lialda) Product and Service

    • Table Heilongjiang Tianhong Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product and Service

    • Table Ferring (Foundation Year, Company Profile and etc.)

    • Table Ferring Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Mesalamine (Lialda) Product and Service

    • Table Holy Stone Healthcare (Foundation Year, Company Profile and etc.)

    • Table Holy Stone Healthcare Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Holy Stone Healthcare Mesalamine (Lialda) Product and Service

    • Table HENGCHENG PHARMACEUTICAL (Foundation Year, Company Profile and etc.)

    • Table HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product and Service

    • Table Lupin (Foundation Year, Company Profile and etc.)

    • Table Lupin Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Mesalamine (Lialda) Product and Service

    • Table DrFalk Pharma (Foundation Year, Company Profile and etc.)

    • Table DrFalk Pharma Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table DrFalk Pharma Mesalamine (Lialda) Product and Service

    • Table Giuliani (Foundation Year, Company Profile and etc.)

    • Table Giuliani Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Giuliani Mesalamine (Lialda) Product and Service

    • Table Tillotts Pharma (Foundation Year, Company Profile and etc.)

    • Table Tillotts Pharma Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tillotts Pharma Mesalamine (Lialda) Product and Service

    • Table Zeria (Foundation Year, Company Profile and etc.)

    • Table Zeria Mesalamine (Lialda) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zeria Mesalamine (Lialda) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US